Committed to sharing our science

Committed to sharing our science

393 results available

Aficamten vs Metoprolol as Monotherapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, ESC 2025

Garcia-Pavia, P et al.

August 30, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

New England Journal of Medicine

Garcia-Pavia, P et al.

August 30, 2025
Toward a Quantitative Understanding of Aficamten Clinical Pharmacology: Population Pharmacokinetic Modeling

CPT: Pharmacometrics & Systems Pharmacology

Xu, D et al.

August 17, 2025
CK-4021586 is a New Class of Cardiac Myosin Inhibitor for Potential Treatment of the Hyper-contractile Subgroup of HFpEF

Oral Presentation, AHA BCVS 2025

Redd, M et al.

July 25, 2025
Participant, Site Personnel and Sponsor Perspectives on Decentralized Trial Features in COURAGE-ALS: a Randomized Clinical Trial

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

Rudnicki, SA et al.

June 27, 2025